https://orcid.org/0000-0002-9373-5473
Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohammed A Omair, Maha M Alshehri, Nouf A Altokhais, Ghada A Aljanobi, Maha I El Dessougi, Amal AlHarthi, Maha A Omair, Suzan M Attar, Sami M Bahlas, Abdullah S Alfurayj, Mansour S Alazmi, Alhussain M Asiri, Mohammed M AlOmair, Lobna Al Juffali & Haya M Almalag. (2022) Exploring Factors Influencing Medication Compliance in Saudi Rheumatoid Arthritis Patients: A Nationwide Cross-Sectional Survey – Results from the COPARA Study. Patient Preference and Adherence 16, pages 1105-1114.
Read now
Read now
Mohammed A Omair, Fatima Al Suwayeh, Alanoud Almashaan, Eman Alqurtas, Mohammed K Bedaiwi, Ibrahim Almaghlouth, Abdulaziz Alkahalaf & Haya M Almalaq. (2021) Cross-Cultural Validation of the 5-Item Compliance Questionnaire for Rheumatology to the Arabic Language in Patients with Rheumatoid Arthritis. Patient Preference and Adherence 15, pages 1461-1467.
Read now
Read now
Articles from other publishers (2)
Mohammed A. Omair, Hanan Al Rayes, Joanne Khabsa, Sally Yaacoub, Sultana Abdulaziz, Ghada A. Al Janobi, Abdulaziz Al Khalaf, Bader Al Mehmadi, Mahasin Al Nassar, Faisal AlBalawi, Abdullah S. AlFurayj, Ahmed Hamdan Al-Jedai, Haya Mohammed Almalag, Hajer Yousef Almudaiheem, Ali AlRehaily, Mohammed A. Attar, Lina El Kibbi, Hussein Halabi, Manal Hasan, Jasvinder A. Singh, Liana Fraenkel & Elie A. Akl. (2022) Recommendations for the treatment of rheumatoid arthritis in Saudi Arabia: adolopment of the 2021 American College of Rheumatology guidelines. BMC Rheumatology 6:1.
Crossref
Crossref
Mohammed A. Omair, Rana Almadany, Maha A. Omair, Hanan Al Rayes, Haya M. Almalag & Aws Alshamsan. (2022) Perception of Biosimilar Biologics and Non-Medical Prescription Switching among Rheumatologists: A Saudi Society for Rheumatology Initiative. Saudi Pharmaceutical Journal 30:1, pages 39-44.
Crossref
Crossref